Growth and survival compositions for cells capable of producing antibodies and methods related thereto
This disclosure relates to growth media and environments for in vitro culturing of cells that produce or are capable of producing antibodies. In certain embodiments, the media comprises IL-6, fibronectin, and typically a saccharide. In certain embodiments, the disclosure contemplates cell culture compositions comprising IL-6 and fibronectin that are derived from proteins secreted from mesenchymal stromal/stem cells (MSCs). In certain embodiments, the disclosure contemplates enclosures comprising culture compositions disclosed herein that are in ambient air or optionally in an environment wherein oxygen is absent or at a low concentration.
1. A method of culturing antibody-secreting cells comprising culturing antibody-secreting cells in a cell growth medium comprising secretions of mesenchymal stromal/stem cells (MSCs).
2. The method of claim 1 , wherein the antibody-secreting cells are plasma cells.
3. The method of claim 2 , wherein the plasma cells have surface molecules in a pattern wherein no or low levels of CD19 are expressed, CD138 is expressed, and CD38 is expressed in higher levels than CD138.
4. The method of claim 1 wherein culturing is done under conditions such that the antibody-secreting cells secrete antibodies for more than 3 days.
5. The method of claim 1 , wherein secretions of mesenchymal stromal/stem cells (MSCs) are derived from extracting the proteins from a group of mesenchymal stromal/stem cells (MSCs) or are derived from replicating or non-replicating mesenchymal stromal/stem cells (MSCs) in the growth medium.
6. The method of claim 1 wherein culturing is in an enclosure wherein the amount of oxygen is less than 5% by volume.
7. The method of claim 1 wherein the growth medium comprises a buffering agent, amino acids, and vitamins.
8. A method of culturing antibody-secreting cells comprising culturing antibody-secreting cells with mesenchymal stromal/stem cells in a cell growth medium.
9. The method of claim 8 , wherein the growth medium further comprises exogenously added APRIL.
10. The method of claim 8 , wherein the antibody-secreting cells are plasma cells.
11. The method of claim 10 , wherein the plasma cells have surface molecules in a pattern wherein no or low levels of CD19 are expressed, CD138 is expressed, and CD38 is expressed in higher levels than CD138.
12. The method of claim 8 wherein culturing is done under conditions such that the antibody-secreting cells secrete antibodies for more than 3 days.
13. The method of claim 8 wherein culturing is in an enclosure wherein the amount of oxygen is less than 5% by volume.
14. The method of claim 8 wherein the growth medium comprises a buffering agent, amino acids, and vitamins.
15. A method of culturing antibody-secreting cells comprising culturing antibody-secreting cells in a cell growth medium comprising secretions of mesenchymal stromal/stem cells (MSCs) and exogenously added APRIL.
16. The method of claim 15 , wherein the antibody-secreting cells are plasma cells.
17. The method of claim 16 , wherein the plasma cells have surface molecules in a pattern wherein no or low levels of CD19 are expressed, CD138 is expressed, and CD38 is expressed in higher levels than CD138.
18. The method of claim 15 wherein culturing is done under conditions such that the antibody-secreting cells secrete antibodies for more than 3 days.
19. The method of claim 15 , wherein secretions of mesenchymal stromal/stem cells (MSCs) are derived from extracting the proteins from a group of mesenchymal stromal/stem cells (MSCs) or are derived from replicating or non-replicating mesenchymal stromal/stem cells (MSCs) in the growth medium.
20. The method of claim 15 wherein culturing is in an enclosure wherein the amount of oxygen is less than 5% by volume.
21. The method of claim 15 wherein the growth medium comprises a buffering agent, amino acids, and vitamins.